Larvol Delta - Efficacy-and-Safety-of-CAP71-as-SecondLine-Treatment-for-Advanced-Biliary-Tract-Cancers-Data-from-a-Randomised-Phase-II-Study

etoposide toniribate (CAP 7.1) - Mundipharma

etoposide IV - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/33121007

Nov 1, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next